Kamada Ltd. (KMDA)

CIK 0001567529 · Healthcare · Drug Manufacturers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024 —
FY-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
—
Document and Entity Information
—
Audit Information
—
Statements
Consolidated Statements of Financial Position
—
Consolidated Statements of Profit Or Loss and Other Comprehensive Income
—
Consolidated Statements of Changes In Equity
—
Consolidated Statements of Changes In Equity (P)
—
Consolidated Statements of Cash Flows
—
Notes
Balances and Transactions With Related Parties
—
Business Combinations
—
Cash and Cash Equivalents
—
Contingent Liabilities and Commitments
—
Cybersecurity Risk Management and Strategy Disclosure
—
Employee Benefit Liabilities, Net
—
Equity
—
Events Subsequent To The Reporting Period
—
Financial Instruments
—
General
—
Guarantees and Charges
—
Income (loss) Per Share
—
Insider Trading Policies and Procedures
—
Intangible Assets, Goodwill and Other Long Term Assets
—
Intangible Assets, Goodwill and Other Long-term Assets
—
Inventories
—
Leases
—
Loans and Financial Liabilities
—
Material Accounting Policies
—
New Accounting Standards Or Amendments and Forthcoming Requirements
—
New Accounting Standards Or Amendments For 2023 and Forthcoming Requirements
—
Operating Segments
—
Other Accounts Payables
—
Other Accounts Receivables
—
Property, Plant and Equipment
—
Share-based Payment
—
Significant Accounting Judgments, Estimates and Assumptions Used In The Preparation of The Financial Statements
—
Supplementary Information To The Statements of Profit and Loss
—
Taxes On Income
—
Trade Payables
—
Trade Receivables, Net
—